- Home
- WST vs CBOE Comparison
WST vs CBOE Comparison
Compare WST & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WST | CBOE |
|---|---|---|
| Founded | 1923 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 25.6B |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | WST | CBOE |
|---|---|---|
| Price | $271.05 | $249.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 11 |
| Target Price | ★ $346.78 | $244.64 |
| AVG Volume (30 Days) | ★ 742.7K | 714.5K |
| Earning Date | 10-23-2025 | 02-06-2026 |
| Dividend Yield | 0.32% | ★ 1.16% |
| EPS Growth | 0.17 | ★ 26.68 |
| EPS | 6.75 | ★ 9.30 |
| Revenue | $3,017,900,000.00 | ★ $4,617,800,000.00 |
| Revenue This Year | $7.01 | N/A |
| Revenue Next Year | $6.20 | $5.52 |
| P/E Ratio | $40.37 | ★ $26.59 |
| Revenue Growth | 4.92 | ★ 16.74 |
| 52 Week Low | $187.43 | $187.30 |
| 52 Week High | $348.90 | $262.98 |
Technical Indicators
Market Signals| Indicator | WST | CBOE |
|---|---|---|
| Relative Strength Index (RSI) | 49.85 | 46.35 |
| Support Level | $264.92 | $244.74 |
| Resistance Level | $275.56 | $253.70 |
| Average True Range (ATR) | 7.46 | 4.41 |
| MACD | -0.37 | -0.82 |
| Stochastic Oscillator | 35.88 | 37.55 |
Price Performance
Historical ComparisonAbout WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.